Research / BWA / Fundamental state Inspectable configuration
State dimensions Filing 0000908255-19-000062 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
81.94% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.33% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
0.54% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
32.50% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
21.03% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
11.08% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.09% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.52% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 18 states Self-history eligible
Dec 31, 2016 0/8 normalized Level 3 Dec 31, 2017 0/9 normalized Level 3 Dec 31, 2017 0/9 normalized Amended as filed Sep 30, 2018 0/8 normalized Level 3 Dec 31, 2018 0/9 normalized Level 3 Mar 31, 2019 0/8 normalized Level 3 Jun 30, 2019 0/8 normalized Level 3 Sep 30, 2019 0/9 normalized Level 3 Dec 31, 2019 0/9 normalized Level 3 Mar 31, 2020 8/9 normalized Level 3 Jun 30, 2020 8/9 normalized Level 3 Sep 30, 2020 8/9 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 81.11%
Current 81.94%
Delta 0.84% Capex Intensity Decreased
Previous 4.98%
Current 4.09%
Delta -0.89% Cash Generation Decreased
Previous 16.74%
Current 14.33%
Delta -2.41% Inventory Pressure Increased
Previous 32.03%
Current 32.50%
Delta 0.48% Margin Increased
Previous 20.11%
Current 21.03%
Delta 0.92% Profitability Decreased
Previous 11.17%
Current 11.08%
Delta -0.10% R And D Intensity Decreased
Previous 4.43%
Current 4.09%
Delta -0.34% Sbc Intensity Increased
Previous 0.35%
Current 0.52%
Delta 0.17% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.